Search clinical trials for: NRAS Mutant
Total 671 results
-
TakedaCompletedCrohn's DiseaseBelgium, Israel, Korea, Republic of, Netherlands, Australia, Denmark, Russian Federation, Hungary, Serbia, Bulgaria, Canada, Germany, Italy, Poland, Slovakia, Czechia, Mexico, Romania, Brazil, Estonia, United States, Bosnia and Herzegovina and more
-
Daiichi Sankyo, Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
University Health Network, TorontoCompletedColorectal Cancer | KRAS Wildtype | NRAS Wildtype | BRAF WildtypeCanada
-
Fabio Iwamoto, MDBristol-Myers SquibbActive, not recruiting
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Spain, Hungary, Israel, United Kingdom, Australia, Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Russian Federation, Sweden, Switzerland, Canada, New Zealand, Norway
-
Hospices Civils de LyonCompleted
-
Washington University School of MedicineUnited States Department of Defense; Puma Biotechnology, Inc.CompletedBreast NeoplasmsUnited States, Canada
-
ES Therapeutics Australia Pty LtdWithdrawn
-
NSABP Foundation IncPuma Biotechnology, Inc.Active, not recruitingMetastatic Colorectal CancerUnited States
-
SanofiCompletedType 2 Diabetes MellitusEstonia, Italy, Israel, United States, Canada, Germany, Romania, Slovakia, Spain
-
ChimerixNo longer available
-
Samsung Medical CenterActive, not recruitingUrothelial CarcinomaKorea, Republic of
-
University of WashingtonNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Leukemia of Ambiguous Lineage | Myeloid NeoplasmUnited States
-
Cheng-Chia (Fred) WuFocused Ultrasound FoundationActive, not recruitingDiffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | Diffuse Pontine and Thalamic GliomasUnited States
-
Targovax ASATerminated
-
H. Lee Moffitt Cancer Center and Research InstituteAprea TherapeuticsCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myeloproliferative NeoplasmUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAdvanced BRAF Mutant MelanomaUnited States
-
Daiichi Sankyo, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)Taiwan
-
Aprea TherapeuticsCompletedMyeloid MalignancyUnited States
-
Azienda Ospedaliero, Universitaria PisanaCompletedGlucose Intolerance | HypertriglyceridemiaItaly
-
PfizerBristol-Myers SquibbCompletedMSS | RAS-mutant Colorectal CancerUnited States, Spain, Belgium, United Kingdom, Netherlands
-
Shanghai Kechow Pharma, Inc.Terminated
-
NYU Langone HealthShireCompletedAttention Deficit Hyperactivity Disorder | Attention Deficit DisorderUnited States
-
Hoffmann-La RocheCompletedHuntington's DiseaseUnited Kingdom, United States, Germany, Canada
-
NSABP Foundation IncWithdrawnColorectal CancerUnited States
-
Kura Oncology, Inc.TerminatedAdvanced Malignant NeoplasmUnited States, Spain
-
NHS TaysideCompleted
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLCCompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Stage IV Non-Small Cell Lung CancerUnited States
-
Nektar TherapeuticsCompletedColorectal CancerUnited States, Belgium, Germany, India, Spain, United Kingdom
-
PfizerCompletedColorectal CancerUnited States, Canada, Australia, Germany, Japan, Netherlands, Spain, France, Belgium, Korea, Republic of, Italy, Norway
-
Daiichi Sankyo, Inc.CompletedEffect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)Drug Interaction PotentialUnited States, New Zealand, Taiwan, Netherlands
-
Kura Oncology, Inc.CompletedThyroid Cancer | Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) | HRAS Mutant Tumor | Other Squamous Cell Carcinoma (SCC) With HRAS Mutant TumorSpain, United States, Korea, Republic of, France, Belgium, Germany, Greece, Italy, Netherlands, United Kingdom
-
BayerCompletedCarcinoma, HepatocellularBelgium, China, Hong Kong, Switzerland, Japan, France, Spain, Germany, United States, Austria, Czechia, United Kingdom, Korea, Republic of, Thailand, New Zealand, Hungary, Israel, Italy, Taiwan, Singapore, Turkey
-
BayerCompletedCarcinoma, HepatocellularBelgium, France, Switzerland, Germany, United States, Austria, New Zealand, Hungary, Korea, Republic of, Italy, Hong Kong, Thailand, Spain, Taiwan, Japan, Czechia, United Kingdom
-
PfizerCompletedMetastatic or Unresectable Cutaneous MelanomaUnited States, Spain, Canada, Italy, United Kingdom, Germany, Korea, Republic of, France, Australia, Czechia, Russian Federation, Turkey, Israel, Netherlands, Greece, Hungary, Japan, Portugal, Argentina, Austria, Belgium, Brazil, Po... and more
-
PfizerCompletedMetastatic Colorectal CancerBelgium, Canada, France, Spain, United States, Italy, Netherlands
-
Novartis PharmaceuticalsCompletedMelanomaCanada, Spain, United Kingdom, Netherlands, United States, Argentina, Australia, France, Germany, Greece, Italy, Russian Federation, Sweden, Ukraine
-
Prof. Dr. med. Dirk SchadendorfCompleted
-
Arog Pharmaceuticals, Inc.Centre Leon Berard; Fox Chase Cancer CenterUnknownGIST With D842V Mutated PDGFRA GeneUnited States, France, Spain, Italy, Germany, Norway, Poland
-
Henan Cancer HospitalCompletedWild-type KRAS,NRAS and BRAF V600E Metastatic Colorectal Cancer
-
TSI, LLCTerminatedAcute Ischemic StrokeNetherlands
-
UNC Lineberger Comprehensive Cancer CenterAstellas Pharma Global Development, Inc.CompletedNon Small Cell Lung CancerUnited States
-
Jennerex BiotherapeuticsTransgeneCompletedColorectal Carcinoma | CRCCanada, United States, France
-
Novartis PharmaceuticalsCompletedHeart Failure and Reduced Ejection FractionUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI); Roche-GenentechCompletedColorectal CancerUnited States
-
Novartis PharmaceuticalsTerminatedSolid Tumors for Phase Ib | Pancreatic Cancer for Phase II | Colorectal Cancer for Phase IIUnited States, Canada, Australia, Belgium, Germany, Netherlands, Spain
-
Novartis PharmaceuticalsTerminatedDiffuse Large B-Cell LymphomaTaiwan, Netherlands, Hong Kong, Italy, Germany, United States, Spain, France, United Kingdom, Korea, Republic of
-
Novartis PharmaceuticalsCompletedCD79 Mutant or ABC-subtype Diffuse Large B-Cell LymphomaTaiwan, Italy, Netherlands, Hong Kong, Germany, United States, Korea, Republic of, France
-
PfizerTerminatedMetastatic Pancreatic Adenocarcinoma | BRAF Mutated MelanomaUnited States, Australia, Belgium, Canada, France, Italy, Spain, United Kingdom
-
Novartis PharmaceuticalsCompletedStomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 ProteinTaiwan, Switzerland, Korea, Republic of, Germany, United States, Japan